65,437 trials
Stroke · Atrial Fibrillation
Primary: Usability of Pulsewatch System (System Usability Scale & Rating Scale) at 14 Days Post the First Randomization — 31 Participants
COVID-19
Primary: Number of Participants With Sustained Recovery — 160; 151 Participants
PTSD and Alcohol Use Disorder
Primary: CAPS-5 Change — 36.720; 38.600; 21.006; 29.872 score on a scale
Cognitive Impairment · RRSO
Primary: Brown Attention Deficit Disorder Scale (BADDS) Change Score (End of Trial Minus Baseline). — -19.68; -4.31 score on a scale
Nutrition Assessment
Primary: Identification of Food Plated Using the Openfit Mobile App — 118; 221 Food items
Presbyopia
Primary: Primary Safety Measure - Partial or Complete Explantation — 2; 4 Eyes
Hearing Loss, Sensorineural · Hearing Loss, Bilateral
Primary: Speech Recognition in Quiet Using CNC (Consonant-Nucleus-Consonant) Word Lists — 6.06; 53.7; 66.61; 69.7 percentage of correctly repeated words — p=.005
Smoking Cessation
Primary: Provider Electronic Referrals to the Maryland Quit Line — 623; 405 referrals
Coronary Artery Disease · Mild Cognitive Impairment · Obesity, Abdominal
Primary: Change in Eigengene Scores — .035; -0.032 Eigen Score
Gingivitis
Primary: Mean Bleeding Index (BI) at Week 12 — 0.45; 0.76 Score on a scale — p=<0.0001
Schizophrenia · Bipolar I Disorder
Primary: Number of Participants With One or More Treatment-Emergent Adverse Events (TEAEs) — 94; 95 Participants
Hepatitis B Virus
Primary: Maximum Observed Plasma Concentration (Cmax) — 8.17 ng/mL
Spinal Cord Injuries
Primary: Change in Maximal Inspiratory Pressure — 8.2; -3.0 cmH2O — p=<0.05
Subclinical Hypothyroidism
Primary: Participants' Willingness to Enter the Trial — 52 Participants
Spinopelvic Relationships as They Relate to Total Hip Arthroplasty's
Primary: Pelvic Tilt (PT) — 40.0; 20.0 degrees